GP

Gurudev Pukkalla

Active Director Director DIN 11002031
DIN 11002031 First appointment Apr 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Gurudev Pukkalla

Data last updated:

Gurudev Pukkalla is a Director at Medway Pharma Private Limited (since 2025). The company operates in Pharma.

DIN 11002031
Primary Designation Director
Industry Pharma
First Appointment 02 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medway Pharma Private Limited U46497AP2025PTC118625
Director02 Apr 20252025Active

Board colleagues of Gurudev Pukkalla

Directorship timeline

Open interactive timeline →
Medway Pharma Private Limited
Premium access

Shareholding and investment profile for Gurudev Pukkalla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gurudev Pukkalla

Gurudev Pukkalla currently holds 1 directorship: Medway Pharma Private Limited (Director, since 02 Apr 2025).

Gurudev Pukkalla was first appointed on 02 Apr 2025 as Director at Medway Pharma Private Limited.

The current boards of Gurudev Pukkalla's companies include Srinivasa Rao Kandi (Medway Pharma Private Limited), Venkata Ramana Kumar Doddi (Medway Pharma Private Limited), Venkata Suresh Boppana (Medway Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available